Literature DB >> 18381374

Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?

A J Kerr1, J Broad, S Wells, T Riddell, R Jackson.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) prevention guidelines typically dichotomise patients by history of CVD, as patients with prior CVD are assumed to be at high CVD risk, whatever their CVD risk profiles.
OBJECTIVE: To assess the appropriateness of this practice by comparing CVD event rates of patients with and without prior CVD, over and above risk predicted by standard CVD risk factors.
METHODS: Between 2002 and 2007 CVD risk assessments were generated using a web-based Framingham risk prediction algorithm in routine primary care. Individual risk profiles were subsequently linked to national hospitalisation and death records. Observed and predicted (Framingham) CVD risk were compared in patients with and without prior CVD.
RESULTS: 35 760 patients were assessed including 10.4% with prior CVD. Of 1216 first CVD events during an average follow-up of 2.05 years, 42% occurred in those with prior CVD. Among those without prior CVD, the predicted Framingham five-year CVD risk was similar to the observed risk extrapolated to five years; in the highest Framingham risk band (>20% five-year risk), observed risk was 25.3%. Among those with prior CVD the observed risk extrapolated to five years rose from 21.7% in the lowest Framingham risk band (<5%) to 49% in the highest (>20%).
CONCLUSIONS: Patients with prior CVD have five-year CVD risks approximately 20% higher, in absolute terms than patients without prior CVD, after accounting for standard risk factors. Almost half the CVD events occurred in those with prior CVD. These patients should be the highest priority for intensive preventive management in primary care.

Entities:  

Mesh:

Year:  2008        PMID: 18381374     DOI: 10.1136/hrt.2007.140905

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  18 in total

Review 1.  The evolution or revolution of statin therapy in primary prevention: where do we go from here?

Authors:  Patricia Rehfield; Colin Kopes-Kerr; Michael Clearfield
Journal:  Curr Atheroscler Rep       Date:  2013-02       Impact factor: 5.113

2.  Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.

Authors:  G Michael Allan; Adrienne J Lindblad; Ann Comeau; John Coppola; Brianne Hudson; Marco Mannarino; Cindy McMinis; Raj Padwal; Christine Schelstraete; Kelly Zarnke; Scott Garrison; Candra Cotton; Christina Korownyk; James McCormack; Sharon Nickel; Michael R Kolber
Journal:  Can Fam Physician       Date:  2015-10       Impact factor: 3.275

Review 3.  Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?

Authors:  Vanessa Selak; Ruth Webster
Journal:  Ther Adv Drug Saf       Date:  2017-12-20

Review 4.  Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.

Authors:  Alma J Adler; Nicole Martin; Javier Mariani; Carlos D Tajer; Onikepe O Owolabi; Caroline Free; Norma C Serrano; Juan P Casas; Pablo Perel
Journal:  Cochrane Database Syst Rev       Date:  2017-04-29

5.  Prognostic value of cardiovascular disease status: the Leiden 85-plus study.

Authors:  Petra G van Peet; Yvonne M Drewes; Anton J M de Craen; Rudi G J Westendorp; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  Age (Dordr)       Date:  2012-07-04

6.  Evaluating a Web-Based Self-Management Intervention in Heart Failure Patients: A Pilot Study.

Authors:  Nazli Bashi; Carol Windsor; Clint Douglas
Journal:  JMIR Res Protoc       Date:  2016-06-20

7.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Authors:  B Mihaylova; J Emberson; L Blackwell; A Keech; J Simes; E H Barnes; M Voysey; A Gray; R Collins; C Baigent
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321

Review 8.  Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes.

Authors:  Enas A Enas; Arun Kuruvila; Pravien Khanna; C S Pitchumoni; Viswanathan Mohan
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375

9.  NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.

Authors:  Petra G van Peet; Yvonne M Drewes; Anton J M de Craen; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

10.  Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.

Authors:  Esther de Beus; Nicolette G C van der Sande; Michiel L Bots; Wilko Spiering; Michiel Voskuil; Frank L J Visseren; Peter J Blankestijn
Journal:  BMJ Open       Date:  2017-09-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.